183 related articles for article (PubMed ID: 19433314)
21. The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity.
Cochran BJ; Gunawardhana LP; Vine KL; Lee JA; Lobov S; Ranson M
BMC Biotechnol; 2009 May; 9():43. PubMed ID: 19442270
[TBL] [Abstract][Full Text] [Related]
22. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
Bin Hafeez B; Adhami VM; Asim M; Siddiqui IA; Bhat KM; Zhong W; Saleem M; Din M; Setaluri V; Mukhtar H
Clin Cancer Res; 2009 Jan; 15(2):452-9. PubMed ID: 19147749
[TBL] [Abstract][Full Text] [Related]
23. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.
Harris NLE; Vennin C; Conway JRW; Vine KL; Pinese M; Cowley MJ; Shearer RF; Lucas MC; Herrmann D; Allam AH; Pajic M; Morton JP; ; Biankin AV; Ranson M; Timpson P; Saunders DN
Oncogene; 2017 Jul; 36(30):4288-4298. PubMed ID: 28346421
[TBL] [Abstract][Full Text] [Related]
24. Systemic and topical administration of spermidine accelerates skin wound healing.
Ito D; Ito H; Ideta T; Kanbe A; Ninomiya S; Shimizu M
Cell Commun Signal; 2021 Mar; 19(1):36. PubMed ID: 33752688
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil extracellular DNA traps promote pancreatic cancer cells migration and invasion by activating EGFR/ERK pathway.
Jin W; Yin H; Li H; Yu XJ; Xu HX; Liu L
J Cell Mol Med; 2021 Jun; 25(12):5443-5456. PubMed ID: 33955688
[TBL] [Abstract][Full Text] [Related]
26. Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt.
Lee SB; Ho JN; Yoon SH; Kang GY; Hwang SG; Um HD
Mol Cells; 2009 Dec; 28(6):583-8. PubMed ID: 19937138
[TBL] [Abstract][Full Text] [Related]
27. [Effect of plasminogen activator urokinase receptor gene on the activation and apoptosis of neutrophil].
Chen J; Zhang RX; Xie M; Ding QJ; Li J
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):877-882. PubMed ID: 38462365
[No Abstract] [Full Text] [Related]
28. SPRY1 promotes the degradation of uPAR and inhibits uPAR-mediated cell adhesion and proliferation.
Liu X; Lan Y; Zhang D; Wang K; Wang Y; Hua ZC
Am J Cancer Res; 2014; 4(6):683-97. PubMed ID: 25520860
[TBL] [Abstract][Full Text] [Related]
29. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.
Meng S; Tripathy D; Shete S; Ashfaq R; Saboorian H; Haley B; Frenkel E; Euhus D; Leitch M; Osborne C; Clifford E; Perkins S; Beitsch P; Khan A; Morrison L; Herlyn D; Terstappen LW; Lane N; Wang J; Uhr J
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17361-5. PubMed ID: 17079488
[TBL] [Abstract][Full Text] [Related]
30. Factor XII and uPAR upregulate neutrophil functions to influence wound healing.
Stavrou EX; Fang C; Bane KL; Long AT; Naudin C; Kucukal E; Gandhi A; Brett-Morris A; Mumaw MM; Izadmehr S; Merkulova A; Reynolds CC; Alhalabi O; Nayak L; Yu WM; Qu CK; Meyerson HJ; Dubyak GR; Gurkan UA; Nieman MT; Sen Gupta A; Renné T; Schmaier AH
J Clin Invest; 2018 Mar; 128(3):944-959. PubMed ID: 29376892
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
Zhang H; Wu G; Chen B
Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
[TBL] [Abstract][Full Text] [Related]
32. Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression.
Kwon YJ; Kwon TU; Shin S; Lee B; Lee H; Park H; Kim D; Moon A; Chun YJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166868. PubMed ID: 37661069
[TBL] [Abstract][Full Text] [Related]
33. uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines.
Biagioni A; Laurenzana A; Chillà A; Del Rosso M; Andreucci E; Poteti M; Bani D; Guasti D; Fibbi G; Margheri F
Cells; 2020 Jan; 9(2):. PubMed ID: 32012858
[TBL] [Abstract][Full Text] [Related]
34. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants.
Leth JM; Newcombe EA; Grønnemose AL; Jørgensen JT; Qvist K; Clausen AS; Knudsen LBS; Kjaer A; Kragelund BB; Jørgensen TJD; Ploug M
Sci Rep; 2023 Oct; 13(1):17248. PubMed ID: 37821532
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.
Nakatsuka E; Sawada K; Nakamura K; Yoshimura A; Kinose Y; Kodama M; Hashimoto K; Mabuchi S; Makino H; Morii E; Yamaguchi Y; Yanase T; Itai A; Morishige KI; Kimura T
Oncotarget; 2017 Oct; 8(52):89887-89902. PubMed ID: 29163796
[TBL] [Abstract][Full Text] [Related]
36. A versatile engineered extracellular vesicle platform simultaneously targeting and eliminating senescent stromal cells and tumor cells to promote tumor regression.
Gong L; Chen Z; Feng K; Luo L; Zhang J; Yuan J; Ren Y; Wang Y; Zheng X; Li Q
J Nanobiotechnology; 2024 Mar; 22(1):105. PubMed ID: 38468249
[TBL] [Abstract][Full Text] [Related]
37. Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs.
Chang YC; Wu CZ; Cheng CW; Chen JS; Chang LC
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895906
[TBL] [Abstract][Full Text] [Related]
38. The m
Xie J; Mo T; Li R; Zhang H; Liang G; Ma T; Chen J; Xie H; Wen X; Hu T; Xian Z; Pan W
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001714
[TBL] [Abstract][Full Text] [Related]
39. BNIP3 enhances pancreatic cancer cell migration and proliferation via modulating autophagy under hypoxia.
Li H; Zhang C; Zhang Q; Jia J; Wang X
Heliyon; 2022 Oct; 8(10):e11190. PubMed ID: 36311367
[TBL] [Abstract][Full Text] [Related]
40. WITHDRAWN: C1qTNF related protein 4 (CTRP4) promotes pancreatic ductal adenocarcinoma cell proliferation and migration via activation of EGFR-PI3K-NF-κB pathway.
Fan H; Zhang M; Li S; Wu J
Oncol Res; 2016 Sep; ():. PubMed ID: 27641756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
